Login
Super Investors Brummer Multi-Strategy AB
BM

Brummer Multi-Strategy AB

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$15.4M
Positions
8
Quarter ended
September 30, 2026
Filed
October 27, 2026

Reported portfolio value by quarter (7 quarters reported)

$24M $1.22M
Q4 23 Q3 25 Q1 26 Q3 26

$3.88M in Q4 2023 → $15.4M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
CS Charles Schwab Corp (the) 28.5% New 44,835 $4.38M
BM Banco Macro S A 16.7% New 38,463 $2.57M
GF Grupo Financiero Galicia S.a 16.6% New 68,506 $2.55M
Aon PLC 14.3% New 7,956 $2.2M
BO Bank Of Amer Corp 9.3% New 26,370 $1.44M
Carlyle Group Inc 5.1% New 19,663 $780K
Jpmorgan Chase & Co 4.8% New 2,246 $743K
Morgan Stanley 4.7% New 3,845 $723K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 6 quarters.

Q3 2026

quarter ended September 30, 2026 · filed October 27, 2026

Company Action Shares changed Value of change % of portfolio
CS Charles Schwab Corp (the) New +44,835 +$4.38M 28.5%
BM Banco Macro S A New +38,463 +$2.57M 16.7%
GF Grupo Financiero Galicia S.a New +68,506 +$2.55M 16.6%
Aon PLC New +7,956 +$2.2M 14.3%
BO Bank Of Amer Corp New +26,370 +$1.44M 9.3%
Newmark Group Inc Exited −80,743 −$1.22M —
Carlyle Group Inc New +19,663 +$780K 5.1%
Jpmorgan Chase & Co New +2,246 +$743K 4.8%
Morgan Stanley New +3,845 +$723K 4.7%

Q2 2026

quarter ended June 30, 2026 · filed July 23, 2026

Company Action Shares changed Value of change % of portfolio
Cbre Group Inc Exited −49,817 −$6.75M —
AR Agree Rlty Corp Exited −87,127 −$6.57M —
Arvinas Inc Exited −285,076 −$3.02M —
Abivax Sa Exited −22,428 −$2.5M —
ML Maravai Lifesciences Hldgs I Exited −759,743 −$2.15M —
WC Wp Carey Inc Exited −28,508 −$1.94M —
Newmark Group Inc New +80,743 +$1.22M 100.0%
Ataibeckley Inc Exited −275,409 −$975K —
Greenland Mines Ltd Exited −370,049 −$122K —

Q1 2026

quarter ended March 31, 2026 · filed May 06, 2026

Company Action Shares changed Value of change % of portfolio
Cbre Group Inc New +49,817 +$6.75M 28.1%
AR Agree Rlty Corp New +87,127 +$6.57M 27.3%
Newmark Group Inc Exited −200,493 −$3.48M —
The Cigna Group Exited −11,818 −$3.25M —
WC Wp Carey Inc New +28,508 +$1.94M 8.1%
IH Iqvia Hldgs Inc Exited −8,183 −$1.84M —
Arvinas Inc Added +118,734 +$1.26M 12.6%
BD Becton Dickinson & Co Exited −5,176 −$1M —
Ataibeckley Inc New +275,409 +$975K 4.1%
AB Atai Beckley Nv Exited −234,915 −$961K —

Showing the 10 largest of 15 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 04, 2026

Company Action Shares changed Value of change % of portfolio
The Cigna Group New +11,818 +$3.25M 19.7%
Arvinas Inc New +166,342 +$1.97M 11.9%
Abivax Sa New +14,375 +$1.94M 11.7%
IH Iqvia Hldgs Inc New +8,183 +$1.84M 11.1%
ML Maravai Lifesciences Hldgs I New +457,707 +$1.49M 9.0%
Ptc Therapeutics Inc Exited −19,142 −$1.17M —
AB Atai Beckley Nv New +234,915 +$961K 5.8%
BD Becton Dickinson & Co Added +4,706 +$913K 6.1%
CI Colliers Intl Group Inc Exited −4,426 −$691K —
Soleno Therapeutics Inc New +8,741 +$405K 2.4%

Showing the 10 largest of 13 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 10, 2025

Company Action Shares changed Value of change % of portfolio
GH Ge Healthcare Technologies I Exited −50,000 −$4.56M —
Newmark Group Inc New +189,519 +$3.53M 64.4%
Ptc Therapeutics Inc New +19,142 +$1.17M 21.4%
CI Colliers Intl Group Inc New +4,426 +$691K 12.6%
BD Becton Dickinson & Co New +470 +$88K 1.6%

Q1 2024

quarter ended March 31, 2024 · filed May 15, 2024

No position changes this quarter.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support